Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog



Hepatitis A/Typhoid Fever

31 May 05

Although difficult to determine accurately, annual global figures for reported cases of hepatitis A and typhoid are estimated to be in the region of 1.5 million and at least 16 million, respectively. Moreover, typhoid fever accounts for up to 600,000 deaths worldwide each year. The two diseases are often found in partnership and have common routes of transmission, particularly where sanitation is poor.
CSF Medical Communications

Novel combinations breathe new life into COPD market

26 May 05

There are 31.2 million COPD sufferers in the US, Europe and Japan - a prevalence rate of approximately 4.4% of the general population. Thus, the development of novel dual-action, once-daily inhaled therapies will provide important new treatment options for COPD and play a major role in the expansion of the market over the next decade.

Will once-daily Kaletra be enough to see off the threat of Reyataz?

20 May 05

In addition to the traditional clinical needs, such as efficacy and resistance profile, product characteristics such as dosing and side effects can be fundamental in maintaining market share in the maturing antiretroviral market. In response to the launch of two once-daily protease inhibitors (PI), Abbott has reformulated its leading PI drug, Kaletra (lopinavir/ritonavir) in a once-daily dose.

Working iN Australia

18 May 05

A brief introduction with useful websites
Paula Mumby

Have you taken your Medication today? Y or N

18 May 05

With UK MP’s, Committees, Regulatory bodies, Health Services and Companies looking for someone to blame for the dangers of patient non-compliance and drug safety issues it’s time to learn how the simplest technology can deliver the biggest rewards and bring you closer to your patients.
Sarah Eadon

Latest antihormonals offer a new standard in breast cancer treatment

13 May 05

For decades, AstraZeneca's tamoxifen has been the standard therapy for hormone-receptor positive breast cancer patients post-surgery. Nearly two-thirds of early-stage breast cancer patients receive the drug post surgery. Now however newer antihormonal agents called aromatase inhibitors, which lower the estrogen level in the body are increasingly being used in place of tamoxifen.

Cancer vaccines: a shot in the dark?

12 May 05

The idea of developing cancer vaccines is far from a novel concept. In fact initial attempts using tumor immunotherapy to combat cancer were made in the late 19th century by the American Dr William Coley. Unfortunately, despite Dr Coley's early efforts and those of numerous others since, there is still no effective therapeutic cancer vaccine on the market.

NHS pharmaceutical messaging service

11 May 05

New on-line system for hospital pharmacies makes ordering medicines easier, quicker and, being paperless, virtually error-free.
Mike Wood

Reduce costs & increase efficiency with SMS

11 May 05

Did you know you can generate SMS messages from any software that can send an email or generate an HTTP request such as Outlook, Lotus Notes..?
Mike Wood

Addressing the crisis facing the Clinical Research Staffing market

29 Apr 05

The Healthcare Industry is currently experiencing the effects of a global shortage of qualified and experienced clinical research professionals – and this situation has evolved into the industry’s very own version of ‘Catch 22’. While employers are looking to hire candidates who are already experienced in the practice of clinical research, new Life Science graduates and others wishing to start on a career in the Healthcare Industry are unable to gain such experience without first being hired.
Kieran Engels
European Director CRAcademy

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.